about
Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases.Personal review: alarmism or legitimate concerns about long-term suppression of gastric acid secretion?Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors.Hypergastrinemia in animals and man: causes and consequences.Review article: the long-term use of proton-pump inhibitors.Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.Rebound acid hypersecretion from a physiological, pathophysiological and clinical viewpoint.Regulation of tumor growth by circulating full-length chromogranin A.Gastro-oesophageal reflux disease in general practice. Last year's guidelines are probably biased.Importance of gastrin in the pathogenesis and treatment of gastric tumors.The safety of proton pump inhibitors.A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem?A randomized, double-blind trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro-oesophageal reflux disease over 5 years.Long-term outcome of surgically and medically treated patients with gastroesophageal reflux disease: a matched-pair follow-up study.Ciprofibrate stimulates the gastrin-producing cell by acting luminally on antral PPAR-alpha.Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trial.Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy.Rabeprazole and psychiatric symptoms.Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial
P2860
Q30487910-72C1CD27-1085-4EB5-A6C2-EBB3BFFD6D6DQ33874484-E722EC33-2FE5-44FF-BC1B-643F40F88931Q33912651-6BDE24B8-B309-4589-88A8-D8BC7E3ACD35Q35821028-1D67CF5E-2B2A-4384-96C4-984F112B738FQ36206584-DEE0E479-40CD-400F-B6F0-D1AB482823B5Q36376528-A42E0F62-DDCD-4A22-8F85-D818113DFF35Q37650556-DED5FE96-9BC0-437C-83D9-39C9C7FEB329Q37687281-357B2EC8-23C1-4024-BD7C-B39988BC0D14Q42219656-BFE004A5-620B-4164-8D55-419814CFDB7DQ43166070-1143038B-93C2-4997-82BA-FA43C36C7B9AQ43591830-2DB360CE-37B2-4E2B-8D4C-5974F434F565Q44052689-5F31E11A-B47B-4735-838C-3E183AE72269Q44299604-70461164-06B8-4A1A-8DAD-23C1DA1CA43AQ46524249-7A9AB62C-F696-4A32-AE9C-CE6FE0A5AA16Q46650017-209C8635-E090-40EB-87A2-2710B49FC8FEQ46946129-6AE33428-9A30-4654-B1F1-FC6F41E566E1Q51546789-BFC30019-146E-4D23-8F54-AC7F78DAE510Q51901862-3C076BFA-D570-4D59-B5BF-79E48AC51E2AQ58003581-2DE34A2B-3395-4933-8EB0-CC457C783B9E
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Personal review: is profound acid inhibition safe?
@ast
Personal review: is profound acid inhibition safe?
@en
type
label
Personal review: is profound acid inhibition safe?
@ast
Personal review: is profound acid inhibition safe?
@en
prefLabel
Personal review: is profound acid inhibition safe?
@ast
Personal review: is profound acid inhibition safe?
@en
P2860
P1476
Personal review: is profound acid inhibition safe?
@en
P2093
P2860
P356
10.1046/J.1365-2036.2000.00681.X
P407
P577
2000-01-01T00:00:00Z